A

The nuclear export inhibitor selinexor improves kidney function in a rat model of focal segmental glomerulosclerosis

American Journal of Physiology-Renal Physiology, vol. 329, pp. F496–F509

Abstract

Focal segmental glomerulosclerosis (FSGS) involves podocyte injury, potentially linked to dysfunctional nuclear pore complexes (NPCs). We show that selinexor (KPT-330), a nuclear export inhibitor, restores NPC function in vitro. In an FSGS rat model, selinexor improves kidney function, lowers serum creatinine and cystatin C levels, and reduces serum lipid levels. However, histological damage persists, indicating partial but not complete protection. These findings highlight NPC-targeted therapies as a potential strategy for treating FSGS.

Authors 14

  1. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    RWTH University Clinic

    Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany

  2. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    RWTH University Clinic

    Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany

  3. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    RWTH University Clinic

    Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany

  4. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    RWTH University Clinic

    Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany

  5. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    RWTH University Clinic

    Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany

  6. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    RWTH University Clinic

    Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany

  7. University of Ioannina · Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    RWTH University Clinic

    University of Ioannina

    Department of Nephrology, School of Medicine, University of Ioannina, Ioannina, Greece

    Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany

  8. RWTH Aachen University

    Affiliation as printed

    RWTH Aachen University

    Institute of Biochemistry and Molecular Cell Biology, Medical School, RWTH Aachen University, Aachen, Germany

  9. Charité - Universitätsmedizin Berlin

    Affiliation as printed

    Charité-Universitätsmedizin Berlin

  10. Charité - Universitätsmedizin Berlin

    Affiliation as printed

    Charité-Universitätsmedizin Berlin

  11. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    RWTH University Clinic

    Department of Cardiology, RWTH University Clinic, Aachen, Germany

    Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany

  12. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    RWTH University Clinic

    Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany

  13. RWTH Aachen University

    Affiliation as printed

    RWTH Aachen University

    Institute of Biochemistry and Molecular Cell Biology, Medical School, RWTH Aachen University, Aachen, Germany

  14. Universitätsklinikum Aachen · RWTH Aachen University

    Affiliation as printed

    RWTH University Clinic

    Division of Nephrology and Clinical Immunology, RWTH University Clinic, Aachen, Germany

Cited by 3 stored of 3

3 results

No patents citing this paper on Lens.org (checked 2026-10-06).

References 63